Varian makes product introductions at ESTRO
Radiation therapy device developer Varian Medical Systems reported that it will be exhibiting a clutch of new technologies and products at the 2007 European Society for Therapeutic Radiology and Oncology meeting in Barcelona, Spain, which begins tomorrow.
Among the new product introductions being showcased will be the Palo Alto, Calif.-based firm’s Smart Segmentation feature for its Eclipse treatment planning system. Smart Segmentation is an automatic software tool that identifies and outlines organs and other structures of interest within diagnostic images of the thorax and male pelvis.
The company will also display another Eclipse planning tool that automatically selects the optimal treatment beam angle for each patient. Additionally, Varian will demonstrate 4D planning software to account for organ motion during radiotherapy treatments.
Varian will also be discussing its new high-definition multi-leaf collimator. The high-definition collimator, with increased resolution utilizing smaller leaves, will be available with the company's Trilogy Tx medical linear accelerator and addresses the needs of stereotactic radiosurgery and stereotactic body radiotherapy, according to Varian.
The company said it will be exhibiting its new spot-scanning proton therapy technology at the conference. Varian acquired Bergisch Gladbach, Germany-based Accel in January this year and will be showcasing the integration of Accel’s particle therapy technology into its products.
Among the new product introductions being showcased will be the Palo Alto, Calif.-based firm’s Smart Segmentation feature for its Eclipse treatment planning system. Smart Segmentation is an automatic software tool that identifies and outlines organs and other structures of interest within diagnostic images of the thorax and male pelvis.
The company will also display another Eclipse planning tool that automatically selects the optimal treatment beam angle for each patient. Additionally, Varian will demonstrate 4D planning software to account for organ motion during radiotherapy treatments.
Varian will also be discussing its new high-definition multi-leaf collimator. The high-definition collimator, with increased resolution utilizing smaller leaves, will be available with the company's Trilogy Tx medical linear accelerator and addresses the needs of stereotactic radiosurgery and stereotactic body radiotherapy, according to Varian.
The company said it will be exhibiting its new spot-scanning proton therapy technology at the conference. Varian acquired Bergisch Gladbach, Germany-based Accel in January this year and will be showcasing the integration of Accel’s particle therapy technology into its products.